Themis Medicare Share Price
Themis Medicare Share Price Today
As of 5 Jul 2026, Themis Medicare share price is ₹118.59. The stock opened at ₹119.82, compared to its previous close of ₹119.11. During today's trading session, Themis Medicare share price moved in the range of ₹118.00 to ₹124.28, with an average price of ₹121.14 for the day. Looking at its last 52-week, the stock has touched a low of ₹64.95 and a high of ₹148.00. On the performance front, Themis Medicare share price has increased by 15.66% over the last six months and is down 5.72% on a year-on-year basis.
Themis Medicare Returns Calculator
Themis Medicare Shareholder Returns
Themis Medicare Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Themis Medicare Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹405.51 | ₹381.76 | ₹354.32 | ₹394.61 |
| Other Income | ₹4.67 | ₹4.76 | ₹11.50 | ₹6.54 |
| Total Revenue | ₹410.18 | ₹386.52 | ₹365.83 | ₹401.16 |
| Total Expenses | ₹376.43 | ₹351.88 | ₹306.93 | ₹317.23 |
| Profit Before Tax | ₹39.67 | ₹53.44 | ₹72.51 | ₹95.26 |
| Tax | ₹9.84 | ₹9.92 | ₹15.61 | ₹22.38 |
| Profit After Tax | ₹29.83 | ₹43.52 | ₹56.90 | ₹72.88 |
| EPS - Basic | ₹3.24 | ₹4.73 | ₹6.18 | ₹79.22 |
| EPS - Diluted | ₹3.24 | ₹4.72 | ₹6.17 | ₹79.07 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹39.67 | ₹53.44 | ₹72.51 | ₹95.26 |
| Income before WC changes | ₹50.57 | ₹51.97 | ₹72.54 | ₹95.02 |
| Change in Assets | -₹14.31 | -₹31.83 | -₹56.66 | -₹28.96 |
| Change in Liabilities | ₹9.20 | ₹10.91 | ₹16.36 | -₹13.59 |
| Change in WC | -₹5.11 | -₹20.92 | -₹40.30 | -₹42.55 |
| Cash flow from Operations | ₹34.71 | ₹22.09 | ₹16.09 | ₹34.39 |
| Cash flow from Investing | -₹12.17 | -₹15.95 | -₹23.96 | -₹15.59 |
| Cash flow from Financing | -₹25.90 | -₹8.77 | ₹0.14 | -₹17.55 |
| Total Cash Flow | -₹3.36 | -₹2.62 | -₹7.73 | ₹1.26 |
| Cash (Start of the year) | ₹9.92 | ₹12.55 | ₹20.28 | ₹19.02 |
| Cash (End of the year) | ₹6.56 | ₹9.92 | ₹12.55 | ₹20.28 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹284.17 | ₹273.25 | ₹249.43 | ₹213.62 |
| Current Assets | ₹303.87 | ₹293.17 | ₹264.53 | ₹214.16 |
| Total Assets | ₹588.03 | ₹566.42 | ₹513.96 | ₹427.78 |
| Current Liabilities | ₹156.12 | ₹154.58 | ₹139.13 | ₹109.52 |
| Net Current Asset | ₹147.74 | ₹138.58 | ₹125.40 | ₹104.64 |
| Non-Current Liabilities | ₹29.31 | ₹34.17 | ₹35.39 | ₹30.77 |
| Equity Capital | ₹402.60 | ₹377.67 | ₹339.44 | ₹287.49 |
| Total Equity & Liabilities | ₹588.03 | ₹566.42 | ₹513.96 | ₹427.78 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹405.51 | ₹381.76 | ₹354.32 | ₹394.61 |
| Other Income | ₹4.67 | ₹4.76 | ₹11.50 | ₹6.54 |
| Total Revenue | ₹410.18 | ₹386.52 | ₹365.83 | ₹401.16 |
| Total Expenses | ₹376.42 | ₹351.85 | ₹306.92 | ₹317.22 |
| Profit Before Tax | ₹33.76 | ₹34.67 | ₹58.91 | ₹83.94 |
| Tax | ₹9.84 | ₹9.92 | ₹15.61 | ₹22.38 |
| Profit After Tax | ₹23.92 | ₹24.75 | ₹43.29 | ₹61.56 |
| EPS - Basic | ₹2.60 | ₹2.69 | ₹4.70 | ₹66.91 |
| EPS - Diluted | ₹2.59 | ₹2.68 | ₹4.70 | ₹66.78 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹33.76 | ₹34.67 | ₹58.91 | ₹83.94 |
| Income before WC changes | ₹50.58 | ₹51.99 | ₹72.57 | ₹95.04 |
| Change in Assets | -₹14.32 | -₹31.89 | -₹56.68 | -₹28.98 |
| Change in Liabilities | ₹9.20 | ₹10.91 | ₹16.34 | -₹13.59 |
| Change in WC | -₹5.12 | -₹20.99 | -₹40.34 | -₹42.57 |
| Cash flow from Operations | ₹34.71 | ₹22.04 | ₹16.07 | ₹34.39 |
| Cash flow from Investing | -₹12.17 | -₹15.96 | -₹23.96 | -₹15.58 |
| Cash flow from Financing | -₹25.90 | -₹8.77 | ₹0.14 | -₹17.55 |
| Total Cash Flow | -₹3.36 | -₹2.68 | -₹7.75 | ₹1.26 |
| Cash (Start of the year) | ₹9.83 | ₹12.51 | ₹20.27 | ₹19.00 |
| Cash (End of the year) | ₹6.47 | ₹9.83 | ₹12.51 | ₹20.27 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹200.50 | ₹195.52 | ₹190.49 | ₹168.32 |
| Current Assets | ₹305.15 | ₹294.44 | ₹265.80 | ₹215.42 |
| Total Assets | ₹505.65 | ₹489.97 | ₹456.29 | ₹383.74 |
| Current Liabilities | ₹156.06 | ₹152.92 | ₹139.07 | ₹109.48 |
| Net Current Asset | ₹149.09 | ₹141.52 | ₹126.72 | ₹105.94 |
| Non-Current Liabilities | ₹29.31 | ₹35.77 | ₹35.39 | ₹30.77 |
| Equity Capital | ₹320.29 | ₹301.28 | ₹281.83 | ₹243.48 |
| Total Equity & Liabilities | ₹505.65 | ₹489.97 | ₹456.29 | ₹383.74 |
About Themis Medicare
Themis Medicare Limited is a research-based pharmaceutical company, which is engaged in the manufacturing of pharmaceutical products, especially in formulation and active pharmaceutical ingredients (API) activity. The Company operates through one segment: Pharmaceuticals. The Company manufactures therapeutic pharma products, differential healthcare products, and APIs based in India. The Company specializes in manufacturing a range of products for application areas like pain management, critical care and anti-infectives. Its analgesic and anti-inflammatory products include Aquadol Tpm Gel, Etojet 90 10'S, Etojet 120 10'S, Etojet Mr Tablets 10'S, Etojet XP Gel, Themidol-P Tab 10's, Dhoom, Aquadol inj, Dyloaqua inj, Joydol -P, Joydol -SP, Joydol -TH, and Nimujet Gel. Its Analgesics products include Anemol, Tazowin, Themidol, Themidol. Its Anesthesia products include Bupicaine 0.25%, Ketmin 2 Vial, Ketmin 5, Ropicaine 2, Themicaine 2%, and more.
Themis Medicare Financial Highlights
- Revenue: Themis Medicare reported revenue of ₹351.60 crore in FY26 vs ₹410.18 crore in FY25. It showed a decrease of 14.28% on a yearly basis.
- Operating Profit: Themis Medicare reported an operating profit of ₹1.93 crore in FY26 vs ₹39.67 crore in FY25. It showed a decrease of 95.13% on a year-on-year basis.
- Net Profit: Themis Medicare reported a net profit of ₹1.14 crore in FY26 vs ₹29.83 crore in FY25. It showed a decrease of 96.18% on a yearly basis.
Themis Medicare Quarterly Result Highlights
- Themis Medicare reported revenue of ₹80.20 crore in Mar 2026, compared with ₹91.41 crore in Dec 2025, representing a decrease of 12.26% on a quarter-on-quarter (QoQ) basis.
- Themis Medicare reported an operating profit of ₹9.06 crore in Mar 2026, compared with ₹10.39 crore in Dec 2025, representing a decrease of 12.80% on a quarter-on-quarter (QoQ) basis.
- Themis Medicare reported a profit of ₹8.89 crore in Mar 2026, compared with ₹10.09 crore in Dec 2025, reflecting a decrease of 11.89% on a QoQ basis.
- The earnings per share (EPS) of Themis Medicare stood at ₹3.24 during Mar 2026.
Similar Stocks
FAQs on Themis Medicare Share Price
What is Themis Medicare share price today?
Themis Medicare share price is ₹118.59 as on 03 Jul, 2026, 15:59 IST.
How has the Themis Medicare share price performed in the past?
In the last 1 year, Themis Medicare delivered a return of -5.72%. The Themis Medicare share price hit a high of ₹148.00 and low of ₹64.95.
How much is the Mutual Fund shareholding in Themis Medicare shares?
The Mutual Fund Shareholding in Themis Medicare was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Themis Medicare shares ?
The 52-week high and low of Themis Medicare share is ₹148.00 and ₹64.95 as of 03 Jul, 2026.
What is the market cap of Themis Medicare?
The market capitalisation of Themis Medicare is ₹1,097.37 Crores as on 03 Jul, 2026.
What are the stock symbols of Themis Medicare?
The stock symbol of Themis Medicare is THEMISMED on the NSE, 530199 on the BSE, and the ISIN is INE083B01024.
What was yesterday's closing price of Themis Medicare shares ?
Themis Medicare shares closed yesterday at ₹119.11 on NSE & ₹119.15 on BSE
How to buy Themis Medicare shares?
To buy Themis Medicare shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Themis Medicare shares on Holidays?
No, shares of Themis Medicare or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Themis Medicare shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Themis Medicare?
The PE and PB ratio of Themis Medicare is 992.92 and 3 respectively, as on 03 Jul, 2026, 15:59 IST.